Masayuki Uegaki
Papers
1
Total Citations
5
H-Index
1
About
Dr. Masayuki Uegaki is a dedicated urologic oncologist whose research focuses on the management of advanced and variant bladder cancers, with a particular emphasis on plasmacytoid urothelial carcinoma—a rare and aggressive subtype. His most cited work, a 2023 case report, documents the first successful use of Avelumab immunotherapy to achieve a durable response in multiple bone and lymph node metastases following radical cystectomy for plasmacytoid variant bladder cancer. This contribution is significant because plasmacytoid tumors often exhibit poor responses to conventional chemotherapy, and Dr. Uegaki's findings offer a promising therapeutic avenue for this challenging disease. With 5 citations to date, this case has already informed clinical decision-making in the field. Dr. Uegaki's work bridges a critical gap in evidence for rare bladder cancer variants, providing actionable insights for oncologists treating patients with limited options. His meticulous reporting and patient-centered approach underscore his commitment to advancing personalized treatment strategies in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1